Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The submission of the first 'smart pill' for market approval, combined with progress in the European nanomedicine landscape, illustrates the positive outlook for drug therapy and health monitoring, explains Christian Martin.
The relationship between technology and religion is diverse and nuanced, but understanding it can be a valuable intellectual exercise, as Chris Toumey explains.
If emerging technologies such as nanotechnology are to reach their full potential we need to radically change our approach to risk, argues Andrew D. Maynard.
The use of silver nanoparticles to clean clothes and the use of magnetite nanoparticles to clean water provide contrasting illustrations of the potential environmental consequences of nanotechnology, as Chris Toumey explains.
When it comes to safety, the jury's still out on which nanoparticle characteristics we should be measuring. But, as Andrew D. Maynard explains, there's a rich history dating back over a hundred years on how we measure them.
More than a decade after it was first published, Chris Toumey revisits a report from the Royal Society on the opportunities and uncertainties of nanotechnology, and finds that it still has plenty to offer.
Emerging technologies need to be developed responsibly if their benefits are to outweigh any potential risks. Yet do entrepreneurs really have the luxury of grappling with future consequences from the get-go, asks Andrew D. Maynard.
A recent conference on the environmental effects of nanoparticles leaves Chris Toumey reflecting on the difficulties of carrying out nanotoxicology research that can be used to develop informed environmental regulation.
